Coronary Artery Disease

What is Acute Coronary Syndrome?

Acute Coronary Syndrome (ACS) is a situation of medical emergency that refers to a group of clinical conditions compatible with acute myocardial ischemia (AMI) and/or infarction. ACS occurs when the blood supply to the heart is blocked due to destabilization of a previously stable atherosclerotic plaque.2,3

There are three classifications according to the presence of Electrocardiography (ECG) abnormalities and Myocardial Infarction (MI):2,3

  • Unstable angina;
  • NSTEMI (non ST-segment-elevation MI);
  • STEMI (ST-segment-elevation MI).2,3

How is AMI diagnosed?

Myocardial infarction (MI), commonly known as a heart attack, is defined pathologically as the irreversible death of myocardial cells caused by ischemia. Clinically, MI is a syndrome that can be recognized by a set of symptoms, chest pain being the hallmark of these symptoms in most cases, supported by biochemical laboratory changes, electrocardiographic (ECG) changes, or findings on imaging modalities able to detect myocardial injury and necrosis.The Fourth Universal Definition of Myocardial infarction proposes that the term acute myocardial infarction(AMI) should be used only when there is acute myocardial damage with clinical evidence of acute myocardial ischemia.4

The diagnosis of AMI requires elevation or drop in troponin values and the presence of at least one of the following criteria:

  1. Symptoms of acute myocardial ischemia;
  2. New ischemic electrocardiographic (EKG) findings;
  3. Development of new abnormal Q waves;
  4. Imaging evidence of loss of viable myocardium or abnormal motion of any of the walls due to ischemic cause; or
  5. Identification of a coronary thrombus on angiography.

Should this not be the case, then the proposal is to refer only to myocardial damage.4 High-sensitivity (hs)–cTn assays are recommended for routine clinical use.5 Myocardial injury is defined as being present when blood levels of cTn are increased above the 99th percentile upper reference limit (URL).5,6 The injury may be acute, as evidenced by a newly detected dynamic rising and/or falling pattern of cTn values above the 99th percentile URL, or chronic, in the setting of persistently elevated cTn levels.

Unmet needs in CAD patient management

1. Screening

Risk prediction in asymptomatic individuals1

2. Rule-out ACS

Only 25% of patients presenting at EDwith chest pain have AMI but 80% will have a prolonged stay in ED: Need to facilitate earlier dischange2

3. Cornerstone to accelerate the diagnosis of AMI

 

High-sensitivity Troponin testings with clinical assessments are the cornerstone for the diagnosis of Acute Myocardial Infarction(AMI)3

4. Patient management

22-25% of patients suspected of AMI remain undiagnosed within 1- hour: Need to improve triaging4

5. Risk stratification

Perioperative myocardial injury(PMI) is an often undetected complication of noncardiac surgery in patients at high-CV risk, and is strongly associated with mortality5

6. Therapy selection

High risk (diabetes & chemotherapy) and medium risk patients (elderly & chronic kidney diseases)6

References

  1. Devereaux PJ, Sessler DI. N Engl J Med 2015;373:2258-2269, 2. Devereaux PJ, et al. JAMA 2017;317:1642-1651; 3. Puelacher C, et al. Circulation 2018;137:1221-1232
  2. Cervellin et al “The clinics of acute coronary syndrome.”
  3. Twerenbold et al “Clinical Use of High-Sensitivity Cardiac Troponin in Patients With Suspected Myocardial Infarction”
  4. Reichlin et al “APACE ” One-Hour Rule-out and Rule-in
  5. Deveraux PJ et al “Association of postoperative high sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing cardiac surgery, 2017.
  6. Tavares et al Endocrinol. Metab. 2016; 60 (2)

*ED: Emergency Department

Article by, Roche

Related Posts

patient-monitor
Assessment of Remote Vital Sign Monitoring and Alarms in a Real-World Healthcare at Home Dataset
Single-Use Wearable Wireless Sensors for Vital Sign Monitoring
patient-monitor
Introducing Bedside Vital Signs Devices at Imperial College Healthcare NHS Trust
work
Anti-Müllerian Hormone as a Marker of Ovarian Reserve and Premature Ovarian Insufficiency in Children and Women With Cancer: A Systematic Review
< Back
There are no products in your cart.
Product total: €0.00
Pay now
0
0 items in your cart - €0.00
Pay now
Scroll to Top